Cumulus Neuroscience
Cumulus Neuroscience provides drug developers with at-home medical-grade tools to collect physiological and digital biomarkers that improve evaluation in neurodegeneration and psychiatry trials. The company combines EEG, tablet-based cognitive assessments, sleep measures, and partner integrations (facial expression and speech analysis) with AI and machine learning analytics on a cloud SaaS platform. Its technology includes patented sensors and algorithms designed to generate objective digital biomarkers for clinical endpoints. The platform targets pharmaceutical and clinical-trial teams running CNS studies and supports integrations with trial workflows and analytics pipelines. Cumulus aims to accelerate and de-risk neuroscience trials by enabling faster, more robust, and cost-effective data collection at scale.
Cumulus Neuroscience
Cumulus Neuroscience provides drug developers with at-home medical-grade tools to collect physiological and digital biomarkers that improve evaluation in neurodegeneration and psychiatry trials. The company combines EEG, tablet-based cognitive assessments, sleep measures, and partner integrations (facial expression and speech analysis) with AI and machine learning analytics on a cloud SaaS platform. Its technology includes patented sensors and algorithms designed to generate objective digital biomarkers for clinical endpoints. The platform targets pharmaceutical and clinical-trial teams running CNS studies and supports integrations with trial workflows and analytics pipelines. Cumulus aims to accelerate and de-risk neuroscience trials by enabling faster, more robust, and cost-effective data collection at scale.